← Open Payments lookup

KORI JUBAN: Open Payments

NPI 1346761301 · WALKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,296 in 105 payments from 19 companies in 2025. Trend: 2023 $1,964 · 2024 $1,678 · 2025 $2,296

Food & beverage: $2,296
CompanyPaymentsAmount
ABBVIE INC.18$279
PFIZER INC.13$275
Bayer Healthcare Pharmaceuticals Inc.7$274
Lilly USA, LLC17$263
Novo Nordisk Inc9$233
GlaxoSmithKline, LLC.13$220
Axsome Therapeutics, Inc.4$193
AstraZeneca Pharmaceuticals LP9$164
Collegium Pharmaceutical, Inc.1$105
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$57

Products named: Kerendia, Auvelity, TRELEGY ELLIPTA, VRAYLAR, Ozempic, PREVNAR 20, MOUNJARO, QULIPTA.

Industry payments across LA — which companies pay providers there.